Long-term prognostic significance of left atrial volume in acute myocardial infarction  by Beinart, Roy et al.
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OBJECTIVES The aim of this study was to evaluate the significance of increased left atrial (LA) volume
determined within the first 48 h of admission as a long-term predictor of outcome in patients
with acute myocardial infarction (MI).
BACKGROUND The LA volume reflects left ventricular (LV) diastolic properties. Whereas other LV Doppler
diastolic characteristics are influenced by acute changes in LV function, LA volume is stable
and reflects diastolic properties before MI.
METHODS Clinical and echocardiographic parameters were prospectively collected in 395 consecutive
patients with acute MI. Patients with LA volume index (LAVI) 32 ml/m2 (normal  2
standard deviations) were compared with those with LAVI 32 ml/m2. Independent clinical
and echocardiographic prognostic risk factors for five years’ mortality were determined by the
Cox proportional hazard model.
RESULTS Left atrial volume index 32 ml/m2 was found in 63 patients (19%) who had a higher
incidence of congestive heart failure on admission (24% vs. 12%, p 0.01), a higher incidence
of mitral regurgitation, increased LV dimensions, and reduced LV ejection fraction when
compared with patients with LAVI 32 ml/m2. Their five-year mortality rate was 34.5%
versus 14.2% (p 0.001). Significant independent risk predictors of five years’ mortality were
age (10 years) (odds ratio [OR] 1.45; 95% confidence interval [CI]1.14 to 1.86), Killip class
2 on admission (OR 2.30; 95% CI 1.29 to 4.09), LAVI32 ml/m2 (OR 2.22; 95% CI 1.25
to 3.96), diabetes (OR 1.94; 95% CI 1.15 to 3.28), and LV restrictive filling pattern (OR
1.89; 95% CI 1.09 to 3.31).
CONCLUSIONS In patients with acute MI, increased LA volume, determined within the first 48 h of
admission, is an independent predictor of five-year mortality with incremental prognostic
information to clinical and echocardiographic data. (J Am Coll Cardiol 2004;44:327–34)
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Toppler indices of left ventricular (LV) diastolic function
ave been shown to predict cardiovascular events in a wide
pectrum of individuals ranging from apparently healthy
ubjects to patients with end-stage dilative cardiomyopathy
1–12). In particular, a restrictive LV filling pattern has been
dentified as a strong predictor of morbidity and mortality in
atients with acute myocardial infarction (MI) (13–19).
ecause the left atrium (LA) is exposed to LV filling
ressures through the open mitral orifice during diastole, its
ize is influenced by the same factors that determine
iastolic filling pressure (20,21). However, in contrast to
ther Doppler variables of LV diastolic function, which are
ffected by acute hemodynamic changes, LA volume is a
ore stable parameter, integrating the effects of elevated LV
lling pressures from preexisting cardiovascular conditions
s well as acute disease. Tsang et al. (22) have demonstrated
he close association between LV diastolic function and LA
olume, which provides a sensitive morphophysiologic ex-
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nd the ‡Cardiology Department, Rabin Medical Center, Petach Tiqvah, Israel
Manuscript received January 15, 2004; revised manuscript received March 16,
c004, accepted March 22, 2004.ression of the severity of LV diastolic dysfunction and
ppears to be a useful index of cardiovascular risk. Møller et
l. (23) have recently shown that LA enlargement implies a
oor prognosis in patients with acute MI. The purpose of
he present study was to assess the significance of LA
olume, as a predictor of five-year all-cause mortality in a
arge and consecutive series of patients with acute MI, and
o compare its power to that of established mortality risk
redictors in this setting.
ETHODS
tudy population. During 1996, 451 consecutive patients
ith documented acute MI were admitted to the coronary
are unit of the Heart Institute of Chaim Sheba Medical
enter and Cardiology Department of the Rabin Medical
enter. Myocardial infarction was detected by the presence
f at least two of the following criteria: chest pain lasting
30 min, typical electrocardiographic changes, and elevated
reatinine kinase-MB fraction. Myocardial infarction loca-
ion was determined by electrocardiographic criteria (24).
welve patients died shortly after admission, before echo-ardiographic assessment could be performed. In 22 patients
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LA Volume in Acute MI July 21, 2004:327–34chocardiographic assessment was not possible within 48 h
f admission because of logistic limitations. In a further 22
atients LA volume could not be determined because of
nadequate imaging. The remaining 395 patients consti-
uted the study population. Patients were included in a
egistry accumulated during the screening period of the
rgatroban in Myocardial Infarction (ARGAMI)-2 Study,
multicenter study designed to assess the safety and relative
fficacy of direct antithrombin (i.e., Argatroban), compared
ith intravenous heparin in patients with acute MI receiv-
ng thrombolytic therapy. Argatroban exerted neither a
avorable nor an adverse detectable effect on outcome. The
tudy protocol was approved by the Sheba and Rabin
edical Center committee on human research. Relevant
ata on medical history, physical examination, laboratory
ndings, and electrocardiograms during the hospital course
nd 30-day follow-up were prospectively collected for all
atients. The data concerning mortality five years after
dmission were obtained from the Israeli population Inte-
ior Ministry Registry.
chocardiography. All patients underwent a complete
chocardiographic examination (Sonos 2500 ultrasound sys-
em with 2.5 MHz transducer, Hewlett-Packard; Andover,
assachusetts) and were recorded on videotapes. The
tudies were interpreted by a single experienced observer
M.S.F.) and all measurements were obtained offline by a
ingle technician. Left ventricular volume was measured by
anually tracing the LV cavity using the biplane modified
impson’s algorithm when 80% of the endocardial border
ould be detected in both the apical four- and two-chamber
iews, and by a single plane when 80% of the endocardial
order could be detected only in the apical four-chamber
iew. Regional myocardial assessment and wall motion score
ndex were determined by assigning a segmental score (1 
ormal, 2  hypokinetic, 3  akinetic, 4  dyskinetic) to
ach of the 16 left ventricular segments, as recommended by
he American Society of Echocardiography (25). All seg-
ent scores were added and divided by the number of
egments analyzed to obtain the wall motion score index.
itral inflow was assessed with pulsed-wave Doppler echo-
ardiography from the apical four-chamber view. The
oppler beam was aligned parallel to the direction of flow
nd a 1- to 2-mm sample volume was placed between the
ips of mitral leaflets during diastole (26). From the mitral
Abbreviations and Acronyms
BSA  body surface area
LA  left atrial
LAVI  left atrial volume index
LV  left ventricle
LVEF  left ventricular ejection fraction
MI  myocardial infarction
MR  mitral regurgitationnflow profile, the E- and A-wave velocity, E-deceleration pime, and E/A velocity ratio were measured. Pulmonary
enous flow was recorded with pulsed-wave Doppler with a
ample volume placed 1 cm into the right upper pulmo-
ary vein. The flow velocities were recorded and the ratio of
ystolic to diastolic forward flow (Si/Di ratio) was calcu-
ated. Mitral regurgitation (MR) was graded by color
oppler flow mapping using an algorithm that integrated
et expansion within the LA (27,28), jet eccentricity (29),
nd size of the proximal area (30–32). Mitral regurgitation
as considered mild when regurgitant jet area occupied
20% of the LA area in the absence of a wall jet and a
roximal isovelocity surface area visible without baseline
hifting. Regurgitation was considered severe in all patients
n whom jet area was 40% of the LA area. Jet eccentricity
r a sizable proximal flow convergence radius (6 mm in a
atient with jet area 20%, and 9 mm in a patient with a
et area between 20% and 40%) raised the grade of MR by
°. The maximal LA volume was measured by the method
f discs using the offline software of Sonos 2500, from the
pical four-chamber view at end-systole, a method shown to
e equivalent to the biplane methods (33). The LA volume
ndex (LAVI) cutoff level of 32 ml/m2 (mean  2 SD) was
sed as has been previously reported (22,23,34). Left ven-
ricular filling patterns were determined according to the
riteria of the European Study Group on Diastolic Heart
ailure (35). Left ventricular restrictive filling pattern was
etermined in patients 50 years when E/A ratio was more
han 3 and E deceleration time 140 ms, and in patients
50 years when E/A ratio was more than 2 and E
eceleration time 140 ms. Left ventricular impaired re-
axation was determiner in patients 50 years when E/A
ation was 1 and E deceleration time more than 240 ms,
nd in patients 50 years when E/A ratio was 0.5 and E
eceleration time more than 280 ms. Stroke distance and
olume were determined by pulse Doppler at the level of the
utflow tract, assuming a circular LV outflow area at the
evel of the insertion of the aortic valve cusps. Myocardial
erformance index was determined as previously reported
36). The sum of isovolumic contraction and relaxation time
as obtained by subtracting ejection time (b) from the
nterval between two mitral inflow periods (a). Myocardial
erformance index then was determined as (a  b)/b. All
easurements were performed by an experienced observer
ho was blinded to the clinical data and were averaged from
hree to five cardiac cycles, in beats with similar lengths
10%).
tatistical analysis. SAS software was used for statistical
nalysis. All continuous variables are presented as mean 
D. Comparison of clinical and echocardiographic charac-
eristics was performed by chi-square analysis for categorical
ariables and by Student t test for echocardiography and
ther continuous variables. A p value 0.05 was considered
ignificant. Multivariate analysis to determine whether
AVI 32 ml/m2 is an independent risk predictor for
ve-year all-cause mortality was performed by the Cox
roportional-hazards model (Release 6.11, SAS Institute,
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July 21, 2004:327–34 LA Volume in Acute MIary, North Carolina). Significant univariate predictors and
ther known risk predictors were entered in the model: age,
ender, Killip class 2, primary reperfusion, diabetes,
ystemic hypertension, paroxysmal atrial fibrillation, previ-
us MI, left ventricular ejection fraction (LVEF), moderate
nd severe MR, LAVI  32 ml/m2, restrictive LV filling
attern, LV end-systolic volume index and body surface area
BSA). A stepwise selection method was used with the
ignificance level of 0.10 for entering and 0.05 for remaining
n explanatory variable. Unadjusted survival curves were
roduced using the Kaplan-Meier method. The log-rank
est was used to compare survival curves. Adjusted survival
urves were constructed using variables entered into the Cox
Table 1. Clinical Characteristics
Characteristic
LAVI <3
(n 
Age, yrs (mean  SD) 60 
Gender, female 65 (2
BSA 1.8 
Risk factors and medical history
Smokers 136 (4
Systemic hypertension 127 (
Diabetes mellitus 77 (
Previous MI 65 (
Previous CVA/TIA 8 (
Previous CABG 11 (
Previous PCI 33 (
Hyperlipidemia 109 (
Myocardial infarction
Killip class 2 (admission) 37 (
Anterior MI 137 (
Peak CK, IU 1,060 
MI type
Q-wave 164 (
Non–Q-wave 144 (
Hospital complications
VT/VF 51 (
Paroxysmal AF 22 (
CHF 37 (
Cardiogenic shock 10 (
Hospital management
Thrombolytic therapy 148 (
PCI (in-hospital) 140 (
CABG (in-hospital) 21 (
In-hospital revascularization 161 (
Intra-aortic balloon pump 14 (
Medical treatment
Heparin 293 (
Beta-blockers 234 (
ACE inhibitors 149 (
Aspirin 314 (
Nitrates 268 (
Digitalis 13 (
Anti-arrhythmic 105 (
Lipid-lowering 34 (
Data are expressed as numbers (%) or mean  SD.
ACE  angiotensin-converting enzyme; AF  atrial fibri
grafting; CHF  congestive heart failure; CK  creatinine
LAVI  left atrial volume index; MI  myocardial infarcti
ischemic attack; VF  ventricular fibrillation; VT  ventricodel set to their mean values in the total population.ESULTS
aseline characteristics of the study population (Table 1). A
otal of 395 patients (84 women), mean age 62  12 years,
onstituted the study population. Left atrial volume index
as 32 ml/m2 in 63 (19%). Compared with patients with
AVI 32 ml/m2, these patients were older, had a greater
revalence of female gender, history of smoking, and cere-
rovascular attack or transient ischemic attack. They pre-
ented more frequently with heart failure (Killip score 2)
n admission. There was no difference in the prevalence of
ypertension, diabetes mellitus, hyperlipidemia, history of
I and revascularization, percutaneous coronary interven-
ion, or coronary artery bypass grafting.
/m2 LAVI >32 ml/m2
(n  63) p Value
69  11 0.001
19 (31.7) 0.05
1.7  0.2 0.001
11 (17.5) 0.001
33 (52.4) 0.04
14 (22.2) 70.8
17 (28.3) 0.15
7 (11.7) 0.001
3 (5.0) 0.55
8 (13.3) 0.47
28 (44.4) 0.08
14 (24) 0.001
23 (36.5) 0.48
1 1,201  1,003 0.38
32 (56) 0.25
21 (37)
13 (20.6) 0.30
4 (6.3) 0.94
14 (22.2) 0.02
4 (6.3) 0.20
25 (43.9) 0.72
19 (31.7) 0.09
5 (8.3) 0.60
23 (36.5) 0.08
7 (11.7) 0.02
52 (86.7) 0.34
29 (48.3) 0.001
31 (51.7) 0.43
52 (86.7) 0.06
44 (73.3) 0.08
5 (8.3) 0.15
17 (28.3) 0.53
7 (11.7) 0.79
; BSA  body surface area; CABG  coronary artery bypass
; CVA  cerebrovascular attack; IU  international units;
I  percutaneous coronary intervention; TIA  transient
chycardia.2 ml
332)
12
0.1)
0.2
1.0)
38.3)
23.2)
20.1)
2.5)
3.4)
10.2)
32.8)
12)
41.3)
1,13
53)
46)
15.4)
6.6)
11.1)
3.0)
46.4)
43.3)
6.5)
48.5)
4.3)
90.7)
72.4)
46.1)
97.2)
83.0)
4.0)
32.5)
10.5)
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LA Volume in Acute MI July 21, 2004:327–34n-hospital course (Table 1). Congestive heart failure was a
ore frequent complication in patients with LAVI 32
l/m2 (14/63 [22.2%] vs. 37/332 [11.1%], p  0.016). There
as no difference in the prevalence of arrhythmias including
trial fibrillation (4/63 [6.3%] vs. 22/332 [6.6%], p 0.94) and
entricular tachycardia or ventricular fibrillation (13/63
20.6%] vs. 51/332 [15.4%], p  0.30), or in the incidence of
ardiogenic shock (4/63 [6.3%] vs.10/332 [3.0%], p  0.19)
uring hospitalization and in MI type (Q-wave vs. non–Q-
ave MI) in the two groups.
Patients with LAVI 32 ml/m2 were treated less with
ntra-aortic balloon pump (4.3% vs. 11.7%, p  0.022). No
Table 2. Echocardiographic Characteristics
Characteristic
LAVI <
(n 
LVEF, % 45.3 
LV end-systolic diameter, cm 3.3 
LV end-diastolic diameter, cm 5.0 
Wall motion score index 1.8 
MV peak E-wave velocity, cm/s 69 
MV peak A-wave velocity, cm/s 70 
MV peak E/A ratio 1.1 
PV Si time velocity integral, cm 10.7
PV Di time velocity integral, cm 7.4
PV Si/Di 1.5
LV filling pattern
Normal 227
Impaired relaxation 34
Restrictive pattern 68
MV E deceleration time, ms 170
LA max volume, ml 42
LA max volume index 23
LV stroke volume, ml 58
LV end-systolic volume, ml 67
LV end-diastolic volume, ml 120
LV end-systolic volume index 36.6
LV end-diastolic volume index 65.6
LV stroke distance, cm 18
MR
None 226
Mild 91
Moderate 12
Severe 3
Data are expressed as numbers (%) or mean  SD.
Di  diastolic time velocity integral of pulmonary vein fl
ventricle; LVEF  left ventricular ejection fraction; MR 
Si  systolic time velocity integral of pulmonary vein flow.
Table 3. Follow-Up
Events
LAVI <3
(n 
Coronary angiography (30 days) 231 (
PCI (30 days) 151 (
CABG (30 days) 32 (
Mortality 7 days 6 (
Mortality 30 days 14 (
Mortality 1 yr 18 (
Mortality 3 yrs 27 (
Mortality 5 yrs 43 (
Data are expressed as numbers (%).
Abbreviations as in Tables 1 and 2.ignificant differences in the treatment with thrombolysis
46.4% vs. 43.9%, p  0.72), percutaneous coronary inter-
ention (43.3% vs. 31.7%, p  0.09) or coronary artery
ypass grafting (6.5% vs. 8.3%, p  0.60) was noted, as well
s no difference in the in-hospital revascularization rate
48.5% vs. 36.5%, p  0.08). At hospital discharge, there
as no difference in the use of aspirin (97.2% vs. 86.7%, p
0.06), angiotensin-converting enzyme inhibitors (46.1%
s. 51.7%, p  0.43), nitrates (83.0% vs. 73.3%, p  0.08),
ntiarrhythmic agents (32.5% vs. 28.3%, p  0.52), or
ipid-lowering drugs (10.5% vs. 11.7%, p 0.79). However,
atients with LAVI 32 ml/m2 were more often receiving
l/m2 LAVI >32 ml/m2
(n  63) p Value
41.9  10.6 0.01
3.6  0.8 0.03
5.3  0.7 0.006
1.9  0.5 0.01
74  26 0.11
74  26 0.27
1.1  0.6 0.60
10.4  3.3 0.68
6.7  3.1 0.31
1.7  0.7 0.19
44 (69.8) 0.57
4 (6.4)
15 (23.8)
171  38 0.74
68  12 0.001
39  7 0.001
56  14 0.32
84  44 0.005
140  54 0.006
4 47.9  23.3 0.001
1 80.3  27.8 0.001
19  4 0.41
28 (44.4) 0.001
25 (39.7)
8 (12.7)
2 (3.2)
 left atrial; LAVI  left atrial volume index; LV  left
regurgitation; MV  mitral valve; PV  pulmonary veins;
/m2 LAVI >32 ml/m2
(n  63) p Value
38 (63.3) 0.20
23 (38.2) 0.23
9 (15.0) 0.24
3 (4.8) 0.15
6 (9.5) 0.08
12 (19.0) 0.001
14 (24.1) 0.001
20 (34.5) 0.00132 m
332)
9.2
0.6
0.5
0.5
18
21
0.7
 3.4
 3.1
 0.5
(69.0)
(10.3)
(20.7)
 35
 10
 5
 15
 26
 34
 13.
 17.
 4
(68.1)
(27.4)
(3.6)
(0.9)
ow; LA
mitral2 ml
332)
71.5)
46.7)
9.9)
1.8)
4.2)
5.4)
8.7)
14.2)
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July 21, 2004:327–34 LA Volume in Acute MIeta-adrenergic blocking agents (72.4% vs. 48.3%), p 
.001).
chocardiographic characteristics. The relationship be-
ween LAVI and other echocardiographic parameters is
hown in Table 2. Left atrial volume index 32 ml/m2 was
ssociated with moderate or severe MR (8/63, 12.7% vs.
2/332, 3.6%; and 2/63, 3.2%, vs. 3/332, 0.9%; respectively,
 0.001), higher LV end-systolic volume (84  44 vs. 67
26, p  0.005), and lower LVEF (41.9  10.6% vs. 45.3
9.2%, p  0.01). Neither the LV filling pattern nor the
/A ratio were significantly different between the groups
ith LAVI 32 ml/BSA and LAVI 32 ml/BSA.
redictors of outcome. During a follow-up period of 5
ears, mortality rate was significantly higher in patients with
AVI 32 ml/m2, (34.5% vs. 14.2%, p  0.001). This
ifference was particularly significant after the first year of
he acute MI (Table 3). There was no significant difference
etween the two groups in mortality rate during the first 30
ays.
nivariate predictors of mortality. Univariate variables
ssociated with five-year all-cause mortality, their odds
atios, and their 95% confidence intervals are shown in
able 4. Univariate variables significantly associated with
ve-year mortality included age, female gender, Killip class
2 on admission, diabetes mellitus, systemic hypertension,
Table 4. Univariate Predictors of 5-Year Mort
Characteristic
Survivors
n  298
Age 60  12
Gender, female 19.8%
Anterior MI 39.9%
Killip class 2 9.6%
Diabetes 20.8%
Hypertension 38.9%
Past MI 20.5%
Primary reperfusion 55.4%
Paroxysmal AF 5.4%
LVEF, % 45  9
LV restrictive pattern 19.9%
LV impaired relaxation pattern 9.8%
E deceleration 140 ms 18.0%
MR (moderate and severe) 5.4%
LAVI 32 ml/m2 12.8%
LV end-systolic volume index 37.8  14.6
BSA 1.8  0.2
*Five-year mortality data are available for 361 patients. †HR c
§HR calculated for a 5 ml/m2 increase. HR calculated for
CI  confidence interval; HR  hazard ratio; MI  my
able 5. Significant Independent Predictors of Five Years’
ortality
Characteristic Risk Ratio 95% CI p Value
ge, 10 yrs 1.45 1.14–1.86 0.003
illip class 2 2.30 1.29–4.09 0.005
iabetes 1.94 1.15–3.28 0.01
AVI 32 ml/m2 2.22 1.25–3.96 0.006
V restrictive filling pattern 1.89 1.09–3.31 0.02bbreviations as in Tables 1 and 4.revious MI, paroxysmal atrial fibrillation, LVEF, LV
lling pattern, moderate and severe MR, LAVI32 ml/m2,
V end-systolic volume index, and E deceleration of 140.
trend for lower mortality was noted in patients treated
ith primary reperfusion (p  0.070).
ndependent predictors of mortality. All significant uni-
ariate variables were entered into the Cox model except for
all motion score index, because it is highly associated with
VEF, and E deceleration of 140 ms, because it is highly
ssociated with restrictive pattern. Independent predictors
f all-cause five-year mortality, their hazard ratios, and 95%
onfidence intervals are shown in Table 5 and Figure 1.
hese include age, Killip class 2 on admission, diabetes
ellitus, LV restrictive filling pattern, and LAVI 32
l/m2. Left atrial volume index 32 ml/m2 had a hazard
atio of 2.22 (95% confidence interval 1.25 to 3.96, p 
.006). Left ventricular ejection fraction, LV end-systolic
olume index, and moderate and severe MR did not prove
o be significant predictors of all-cause mortality when
AVI was included in this model. A separate analysis using
he same model was performed on the 313 patients with first
Deceased
n  63 HR (95% CI) p Value
69  12 1.68 (1.35–2.10)† 0.001
30.6% 1.70 (1.00–2.93) 0.05
46.0% 1.28 (0.78–2.10) 0.33
34.4% 4.18 (2.46–7.10) 0.001
41.3% 2.38 (1.44–3.92) 0.001
54.0% 1.71 (1.04–2.81) 0.03
32.3% 1.76 (1.03–2.99) 0.04
47.6% 0.74 (0.45–1.22) 0.24
12.7 2.45 (1.16–5.14) 0.02
42  10 0.69 (0.54–0.89)‡ 0.001
30.6% 1.72 (1.00–2.99) 0.05
8.1% 0.94 (0.37–2.40) 0.90
24.2% 1.41 (0.79–2.52) 0.25
14.3% 2.63 (1.30–5.33) 0.007
31.8% 2.78 (1.63–4.72) 0.001
2.5  21.7 1.08 (1.01–1.15)§ 0.02
1.7  0.2 0.82 (0.71–0.95) 0.007
ed for a 10-year increase. ‡HR calculated for a 10% increase.
ecrease.
al infarction. Other abbreviations as in Tables 1 and 2.
igure 1. Independent five-year mortality risk predictors of all patients;
azard ratio (95% confidence interval [CI]). LV  left ventricular; LAVI
left atrial volume index.ality*
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LA Volume in Acute MI July 21, 2004:327–34I and revealed that age, diabetes, LVEF, and LAVI 32
l/m2 were significant independent predictors of five-year
ll-cause mortality (Table 6, Fig. 2).
Kaplan-Meier survival curves for patients with LAVI
32 ml/m2 and those with LAVI 32 ml/m2 are shown in
igure 3 and adjusted survival curves in Figure 4.
ISCUSSION
his prospective study confirms the observation that LAVI
btained early within the first 48 h of admission is a
owerful independent predictor of survival after acute MI.
oreover, new findings include the fact that LAVI be-
omes a significant independent predictor of mortality
ithin the first year following acute MI and is even more
owerful for predicting five-year survival, and that LA
olume obtained early upon admission is a more powerful
ndependent long-term mortality predictor than LV volume
nd the presence of MR.
Left ventricular diastolic dysfunction is a well-established
arker for risk stratification of patients with acute MI
13–19). However, most of the diastolic parameters that
ere previously assessed were affected by acute hemody-
amic changes. In contrast, LA volume is influenced by LV
lling pressure before acute MI and has been shown to be a
ensitive expression of the severity of prior diastolic dysfunc-
ion (37). Left atrial volume is increased by a number of
athologic processes leading to diastolic LV dysfunction,
uch as systemic hypertension and diabetes mellitus. It also
eflects LV diastolic dysfunction secondary to LV systolic
ysfunction due to previous LV insults, the long-term
resence of MR and its severity, and the presence of atrial
brillation. As a common pathway reflecting all these
rocesses that decrease “cardiac reserve” in patients with
able 6. Significant Independent Predictors of Five Years’
ortality, in Patients With a First MI
Characteristic Risk Ratio 95% CI p Value
ge, 10 yrs 1.53 1.15–2.03 0.004
iabetes 2.07 1.10–3.88 0.024
VEF%, 10% 0.70 0.50–0.98 0.039
AVI 32 ml/m2 2.05 1.02–4.11 0.044
bbreviations as in Tables 1 and 4.
igure 2. Independent five-year mortality risk predictors of patients with
rst myocardial infarction only; hazard ratio (95% confidence interval
CI]). LAVI  left atrial volume index; LVEF  left ventricular ejection
raction. ficute MI, it becomes a powerful predictor of long-term
utcome.
Møller et al. (23) showed for the first time the importance
f LA volume as a predictor of post-MI survival. They
tudied 314 patients retrospectively and showed that LAVI
f 32 ml/m2 (normal  2 standard deviations) was a
owerful independent predictor of all-cause mortality dur-
ng a mean follow-up period of 15 months.
The present study reconfirmed these findings prospec-
ively and extended them further. The 395 consecutive
atients with documented acute MI in our study were
ollowed for 5 years and, despite the fact that they were
igure 3. Kaplan-Meier survival curves of patients with left atrial (LA)
olume index 32 ml/m2 and for patients with LA volume index 32
l/m2. The log-rank test was used to compare survival curves. p  0.0001.
igure 4. Adjusted survival curves of patients with left atrial (LA) volume
ndex32 ml/m2 and with LA volume index32 ml/m2 were constructed
sing variables entered into the Cox model: age, gender, Killip class 2,
rimary reperfusion, diabetes, systemic hypertension, paroxysmal atrial
brillation, previous myocardial infarction, left ventricular ejection fraction,
oderate and severe mitral regurgitation, and restrictive left ventricularlling pattern. p  0.02.
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July 21, 2004:327–34 LA Volume in Acute MIignificantly younger (mean age of 62 years vs. 70 years),
ppeared to have had a lower mortality rate, and smaller
ean LA volume, their LAVI maintained its significant
redictive power. Left atrial volume was estimated in our
tudy from a single plane (apical four-chamber view),
echnically simpler than the biplane method used before,
hile maintaining its diagnostic power as previously as-
umed (33).
Interestingly, the multivariate analysis showed that other
nown powerful predictive variables such as LVEF, LV
nd-systolic volume index, and significant MR, lost their
ndependent significance when LAVI was included in the
tatistical model. In patients with a first MI, Killip class on
dmission did not prove to be an independent predictor of
ve-year mortality, whereas LVEF did. Left atrial volume
ndex maintained its significance in the subgroup of patients
ith a first acute MI.
imitations. The study shows the significance of LAVI
btained from echocardiographic studies performed early
ithin the first 48 h of admission of patients with acute MI.
t this early stage LV dysfunction may still be reversible and
ay not reflect the full remodeling process after the infarc-
ion. Therefore, these findings may not apply to studies
erformed at a later stage. The LA is a complicated
hree-dimensional structure and the geometric algorithm
sed only estimates its volume. Three-dimensional imaging
ay be a more accurate method of defining LA volume and
unction. Since 1996, the percentage of patients undergoing
rimary percutaneous coronary intervention rather than
hrombolysis has increased in our institutions, as has the use
f angiotensin-converting enzyme inhibitors and lipid-
owering drugs. Although these trends may have reduced
he overall cardiovascular mortality, they are unlikely to
ffect the prognostic value of LA volume.
onclusions. Our study confirms the conclusions of a
revious study (23) that increased LA volume is an inde-
endent risk predictor of all-cause mortality of patients with
cute MI. Furthermore, it shows the long-term (five-year)
urvival prognostic significance of LA volume obtained early
n admission over LV dimensions and significant MR with
n incremental value to other clinical risk predictors.
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